Skip to content
Fencer Vulns
medium 6.5

CVE-2026-52866 json

Apollo Pharmacy Blood Glucose Monitoring System APG-01 BT Missing Authorization

published 2026-06-18 4 mo ago modified 2026-10-26 13 d ago also EUVD-2026-37970

cvss
6.5
version 3.1, CNA
cisa kev
Not listed
not in CISA's catalog
epss
0.3%
EPSS 0.3% chance of exploitation in 30 days, percentile 28%
public exploits
0
none known

Summary

An attacker within BLE communication range can monopolize the device's only available BLE connection slot, preventing legitimate users or applications from establishing a connection.

Vendor advisories

What the vendors themselves say about their products: affected, fixed or not affected, and what to do.

cisa ICSMA-26-169-01 updated cvss 6.5

Apollo Pharmacy Blood Glucose Monitoring System APG-01 BT

  • Apollo Pharmacy Blood Glucose Monitoring System (Model No. APG-01 BT) 0x0110_v1.1.0
    affected: mitigation “Apollo Pharmacy did not respond to CISA's requests to coordinate. Users are encouraged to reach out to Apollo Pharmacy directly for more information:https://www.apollopharmacy.in/contact-us.” apollopharmacy.in

From CISA ICS and IT advisories (CSAF, https://github.com/cisagov/CSAF), a U.S. Government work; changed: reduced to products, statuses and remediations. CISA notification · csaf

CISA SSVC

Exploitation
none
Automatable
no
Technical impact
partial
Assessed
4 mo ago

Exploit prediction

0.35% chance of exploitation in the next 30 days, higher than 28% of all scored CVEs (FIRST EPSS, 2026-11-08).

CVSS scores

assigned by version score vector
CNA 3.1 6.5 CVSS:3.1/AV:A/AC:L/PR:N/UI:N/S:U/C:N/I:N/A:H
CNA 4.0 7.1 CVSS:4.0/AV:A/AC:L/AT:N/PR:N/UI:N/VC:N/VI:N/VA:H/SC:N/SI:N/SA:N
CNA 4.0 7.1 CVSS:4.0/AV:A/AC:L/AT:N/PR:N/UI:N/VC:N/VI:N/VA:H/SC:N/SI:N/SA:N/E:X/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X

Affected products

  • Apollo Pharmacy Blood Glucose Monitoring System (Model No. APG-01 BT)

Classification

Weakness

References

Sources

Fencer Vulns keeps one entry per vulnerability: the CVE id wins, then GHSA, and records that alias each other are merged, except that two CVEs always keep separate entries. The same data is available as JSON.